Postgrad Med J

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Postgraduate Medical Journal 2007;83:244-250; doi:10.1136/pgmj.2006.052100
Copyright © 2007 The Fellowship of Postgraduate Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sampsonas, F.
Right arrow Articles by Spiropoulos, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sampsonas, F.
Right arrow Articles by Spiropoulos, K.

REVIEW

DNA sequence variations of metalloproteinases: their role in asthma and COPD

Fotis Sampsonas , Alexander Kaparianos , Dimosthenis Lykouras , Kiriakos Karkoulias , Kostas Spiropoulos

Department of Internal Medicine, Division of Pneumology, University Hospital of Patras, Patras, Greece

Correspondence to:
Correspondence to:
Kostas Spiropoulos
University Hospital of Patras, 26500, Rio, Patras, Greece; k-spiropoulos{at}hotmail.com

Asthma and chronic obstructive pulmonary disease (COPD) are complex genetic diseases that cause considerable morbidity and mortality worldwide. Genetic variability interacting with environmental and ethnic factors is presumed to cause tobacco smoke susceptibility and to influence asthma severity. A disintegrin and metalloproteinase 33 (ADAM33) and matrix metalloproteinase-9 (MMP9) appear to have important roles in asthma and COPD pathogenesis. ADAM33 and MMP9 genetic alterations could possibly contribute to the establishment and progression of these multifactorial diseases, although their association with the clinical phenotypes has not yet been elucidated. However, the occurrence of these alterations does not always result in clear disease, implying that either they are an epiphenomenon or they are in proximity to the true causative alteration. This review summarises the most recent literature dealing with the genetic variations of metalloproteinases and outlines their potential pathogenetic outcome.


Abbreviations: ADAM33, a disintegrin and metalloproteinase 33; BHR, bronchial hyper-responsiveness; COPD, chronic obstructive pulmonary disease; ECM, extracellular matrix; LD, linkage disequilibrium; MMP, matrix metalloproteinase; SNP, single nucleotide polymorphism

Keywords: ADAM33; asthma; COPD; genes; metalloproteinases; polymorphisms







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 The Fellowship of Postgraduate Medicine